Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 57,000 CLDX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 57,000 | n/a |
| Jun 9, 2025 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 72,000 | n/a |
| Jun 17, 2024 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 72,000 | n/a |
| Jun 13, 2024 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 15,000 | $40.6K |
| Jun 11, 2024 | Celldex Therapeutics, Inc. (CLDX) | Sale | 45,000 | $1.59M |
| Jun 20, 2023 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 80,000 | n/a |
| Aug 19, 2022 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 19,000 | $197.2K |
| Jun 17, 2022 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 76,000 | n/a |
| Nov 16, 2021 | Celldex Therapeutics, Inc. (CLDX) | Exercise/Conversion | 4,600 | $47.7K |
| Jun 21, 2021 | Celldex Therapeutics, Inc. (CLDX) | Grant/Award | 72,000 | n/a |